|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
3
|
Resverlogix Corp.
|
Dec 22, 2020 01:32PM
|
|
Re: Award of deferred shares and restricted shares
|
10
|
Resverlogix Corp.
|
Dec 20, 2020 06:43PM
|
|
Re: Institutional Investors
|
5
|
Resverlogix Corp.
|
Dec 13, 2020 06:41PM
|
|
Re: AGM Resolution
|
6
|
Resverlogix Corp.
|
Dec 04, 2020 06:58PM
|
|
Re: What's the deal?
|
2
|
Resverlogix Corp.
|
Nov 28, 2020 04:15PM
|
|
Re: 3rd party rumour ..
|
4
|
Resverlogix Corp.
|
Nov 26, 2020 04:37PM
|
|
Re: AGM
|
3
|
Resverlogix Corp.
|
Nov 21, 2020 10:07AM
|
|
Re: Today's stream - link
|
9
|
Resverlogix Corp.
|
Nov 20, 2020 12:12PM
|
|
Re: Dec 22
|
4
|
Resverlogix Corp.
|
Nov 10, 2020 07:02PM
|
|
Re: Presentation
|
5
|
Resverlogix Corp.
|
Oct 23, 2020 11:29AM
|
|
Re: The problem...as I see it
|
3
|
Resverlogix Corp.
|
Oct 21, 2020 11:22AM
|
|
Re: The problem...as I see it
|
4
|
Resverlogix Corp.
|
Oct 16, 2020 06:56PM
|
|
Re: December 22, 2020.
|
9
|
Resverlogix Corp.
|
Oct 10, 2020 10:14AM
|
|
Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications
|
6
|
Zenith Epigenetics
|
Oct 05, 2020 07:08PM
|
|
Re: Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020
|
5
|
Resverlogix Corp.
|
Sep 19, 2020 04:02PM
|
|
Re: Ground Hog Day
|
2
|
Resverlogix Corp.
|
Sep 18, 2020 04:24PM
|
|
Re: Rought Transcript: RVX Presentation at GCFF Virtual Conference – Investing In Innovation – 09/10/2020
|
4
|
Resverlogix Corp.
|
Sep 18, 2020 09:07AM
|
|
Re: August 2, 2020 Article - British Journal of Anesthesia - mentions Apabetalone & COVID
|
5
|
Resverlogix Corp.
|
Sep 10, 2020 11:03AM
|
|
BNP
|
6
|
Resverlogix Corp.
|
Sep 01, 2020 11:03AM
|
|
Re: Thinking back on an older discussion and wishing we had an update - Few items
|
7
|
Resverlogix Corp.
|
Jul 24, 2020 11:40AM
|
